261 related articles for article (PubMed ID: 34625841)
1. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
[TBL] [Abstract][Full Text] [Related]
2. Temporal Trends in Clinician-Assessed and Patient-Reported Swallowing Outcomes in Oropharyngeal Cancer Patients.
Kabalan S; Papadopoulos-Nydam G; Jeffery CC; Rieger J; Constantinescu G
Am J Speech Lang Pathol; 2023 Mar; 32(2):492-505. PubMed ID: 36630888
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal dysphagia assessment in adult patients with nephropathic cystinosis using the Modified Barium Swallow Impairment Profile.
Sullivan S; Grant N; Hammond C; David WS; Eichler F; Sadjadi R
Muscle Nerve; 2022 Aug; 66(2):223-226. PubMed ID: 35616433
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Evaluation of Swallowing with Videofluoroscopy in Patients with Locally Advanced Head and Neck Cancer After Chemoradiation.
Xinou E; Chryssogonidis I; Kalogera-Fountzila A; Panagiotopoulou-Mpoukla D; Printza A
Dysphagia; 2018 Oct; 33(5):691-706. PubMed ID: 29572573
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Interplay Between Radiotherapy Dose and Physiological Changes in the Swallowing Mechanism in Patients Undergoing (Chemo)radiotherapy for Oropharynx Cancer.
Hutchison AR; Wishart LR; Brown B; Ward EC; Hargrave C; Brown E; Porceddu S
Dysphagia; 2022 Jun; 37(3):567-577. PubMed ID: 33966115
[TBL] [Abstract][Full Text] [Related]
6. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia.
Barbon CEA; Peterson CB; Moreno AC; Lai SY; Reddy JP; Sahli A; Martino R; Johnson FM; Fuller CD; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):956-964. PubMed ID: 36074459
[TBL] [Abstract][Full Text] [Related]
7. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
[TBL] [Abstract][Full Text] [Related]
8. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?
Hutcheson KA; Barrow MP; Lisec A; Barringer DA; Gries K; Lewin JS
Laryngoscope; 2016 May; 126(5):1108-13. PubMed ID: 26542529
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
Peng LC; Hui X; Cheng Z; Bowers MR; Moore J; Cecil E; Choflet A; Thompson A; Muse M; Kiess AP; Page BR; Gourin CG; Fakhry C; Szczesniak M; Maclean J; Wu P; Cook I; McNutt TR; Quon H
Oral Oncol; 2018 Sep; 84():25-30. PubMed ID: 30115472
[TBL] [Abstract][Full Text] [Related]
10. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
[TBL] [Abstract][Full Text] [Related]
11. Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma.
Martin A; Murray L; Sethugavalar B; Buchan C; Williams GF; Sen M; Prestwich RJD
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):756-763. PubMed ID: 30025978
[TBL] [Abstract][Full Text] [Related]
12. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
[TBL] [Abstract][Full Text] [Related]
13. Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
Hutcheson KA; Barbon CEA; Alvarez CP; Warneke CL
Cancer; 2022 Apr; 128(7):1458-1466. PubMed ID: 34985765
[TBL] [Abstract][Full Text] [Related]
14. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
[TBL] [Abstract][Full Text] [Related]
15. Office-Based Cricopharyngeus Balloon Dilation for Post Chemoirradiation Dysphagia in Nasopharyngeal Carcinoma Patients: A Pilot Study.
Fong R; Sun N; Ng YW; Rumbach AF; Ward EC; Tsang R
Dysphagia; 2019 Aug; 34(4):540-547. PubMed ID: 30888528
[TBL] [Abstract][Full Text] [Related]
16. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
[TBL] [Abstract][Full Text] [Related]
19. Relating Physiologic Swallowing Impairment, Functional Swallowing Ability, and Swallow-Specific Quality of Life.
Hazelwood RJ; Armeson KE; Hill EG; Bonilha HS; Martin-Harris B
Dysphagia; 2023 Aug; 38(4):1106-1116. PubMed ID: 36229718
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the Effect of Radiotherapy Dose on Chewing and Swallowing Structures in Head and Neck Cancer Patients Treated with Concomitant Chemoradiotherapy.
Baştuğ Dumbak A; Esen Aydınlı F; Yazıcı G; İncebay Ö; Yıldız Z; Yüce D; Süslü N; Kuşçu O; Kulak Kayıkcı ME
Dysphagia; 2022 Dec; 37(6):1400-1413. PubMed ID: 35075541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
